Press "Enter" to skip to content

Posts published by “admin”

Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company – GlobeNewswire

admin 0

Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company  GlobeNewswire MIRAMAR, Fla., June 25, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation…

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial – The Lancet

admin 0

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial  The Lancet IPH4102 is a first-in-class monoclonal antibody targeting…

Uterine Cancer Therapies and Diagnostic Market 2019 Industry Size and Share Evolution to 2024 by Growth Insight, Key Development, Trends and Forecast by Market Reports World – Spaceflight News

admin 0

Uterine Cancer Therapies and Diagnostic Market 2019 Industry Size and Share Evolution to 2024 by Growth Insight, Key Development, Trends and Forecast by Market Reports World  Spaceflight News Uterine Cancer Therapies…

Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres® Y-90 resin microspheres content= – PR Newswire UK

admin 0

Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres® Y-90 resin microspheres content=  PR Newswire UK Physicians and employees recognized for their role in this milestone and impact made on…